Historical record - last NADAC effective date: 2/21/2024
Product Information
HYDROXYCHLOROQUINE 200 MG TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1760 per EA under NDC 57664076113. Its NADAC has been published 162 times since Jan 20, 2021.
FDA first approved this application on May 8, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664076113
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA201691FDA Approved
5/8/2018
TE Code
AB
On Market Since
6/18/2018
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYCHLOROQUINE 200 MG TAB has been published 162 times since Jan 20, 2021, and over the history we have for it it has declined 37.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1760 per EA |
|---|---|
| All-time high | $0.2863 (May 12, 2021) |
| All-time low | $0.1760 (Feb 21, 2024) |
| Median price | $0.2261 |
| Average price | $0.2337 |
| Largest weekly change | -18.2% (Dec 22, 2021) |
| Weeks tracked | 162 |
| Tracking since | Jan 20, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-13.2%
5Y
-33.8%
All
-37.3%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYCHLOROQUINE 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYCHLOROQUINE 200 MG TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.1760 per EA (NDC 57664076113), effective Feb 21, 2024.
How has the price of HYDROXYCHLOROQUINE 200 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has declined 37.3%. It has been tracked across 162 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for HYDROXYCHLOROQUINE 200 MG TAB?
Since Jan 20, 2021, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has ranged from a low of $0.1760 (Feb 21, 2024) to a high of $0.2863 (May 12, 2021), with a median of $0.2261 per EA.
Are there cheaper alternatives to HYDROXYCHLOROQUINE 200 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROXYCHLOROQUINE 200 MG TAB, is $0.1485 per EA — about 16% below HYDROXYCHLOROQUINE 200 MG TAB.
Who manufactures HYDROXYCHLOROQUINE 200 MG TAB?
HYDROXYCHLOROQUINE 200 MG TAB (NDC 57664076113) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.